| Original language | English (US) |
|---|---|
| Pages (from-to) | E222-E225 |
| Journal | American journal of hematology |
| Volume | 95 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2020 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease. / Sidana, Surbhi; Murray, David L.; Dasari, Surendra; Go, Ronald S.; Muchtar, Eli; Willrich, Maria A.; Snyder, Melissa; Kohlhagen, Mindy; Lust, John A.; Kourelis, Taxiarchis V.; Kumar, Shaji K.; Dispenzieri, Angela; Gertz, Morie A.
In: American journal of hematology, Vol. 95, No. 9, 01.09.2020, p. E222-E225.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease
AU - Sidana, Surbhi
AU - Murray, David L.
AU - Dasari, Surendra
AU - Go, Ronald S.
AU - Muchtar, Eli
AU - Willrich, Maria A.
AU - Snyder, Melissa
AU - Kohlhagen, Mindy
AU - Lust, John A.
AU - Kourelis, Taxiarchis V.
AU - Kumar, Shaji K.
AU - Dispenzieri, Angela
AU - Gertz, Morie A.
N1 - Funding Information: S.S.: Consultancy: Janssen; D.L.M.: Intellectual property rights on Mass‐Fix assay; S.D.: Intellectual property rights on Mass‐Fix assay. A.D.: Research Funding from Celgene, Takeda, Prothena, Jannsen, Pfizer, Alnylam, G.S.K.; S.K.K.: Research Funding and membership on an entity's Board of Directors or advisory committees: AbbVie, Celgene, Janssen, KITE, Merck. Membership on an entity's Board of Directors or advisory committees: Oncopeptides, Takeda. Research funding from Novartis and Roche.; M.A.G.: Honoraria/consultancy from Ionis, Alnylam, Prothena, Celgene, Janssen, Specytrum, Annexon, Apellis, Amgen, Medscape, Abbvie, Research to Practice, Physcians Education Resource and Teva.
PY - 2020/9/1
Y1 - 2020/9/1
UR - http://www.scopus.com/inward/record.url?scp=85086326856&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086326856&partnerID=8YFLogxK
U2 - 10.1002/ajh.25843
DO - 10.1002/ajh.25843
M3 - Letter
C2 - 32356376
AN - SCOPUS:85086326856
VL - 95
SP - E222-E225
JO - American Journal of Hematology
JF - American Journal of Hematology
SN - 0361-8609
IS - 9
ER -